In a study of Medicare beneficiaries, researchers from Brigham and Women’s Hospital found that one year after hospitalization for heart failure, 6 percent of patients had progressed to dialysis.
FDA details new ‘platform technology’ process that could accelerate cell and gene therapy approvals
The FDA on Tuesday released a long-awaited draft guidance explaining how companies can win designations for platform technologies, a regulatory step that could speed up